Have you checked out our newsletter?
Stay ahead with expert insights, strategic tips, and industry trends—all designed to boost your brand's med comm initiatives.
"*" indicates required fields
Get fresh insights and candid perspectives on timely issues impacting the pharmaceutical industry from our blog.
The Latest News
DOLs: A New Frontier
Whether you call them Key Opinion Leaders (KOLs) or Key External Experts (KEEs), success in the pharmaceutical space has always started with one essential task: identifying the right experts to engage, influence, and collaborate with. These are the clinicians who publish groundbreaking research, present at major conferences, and serve on
Industry Happenings – October 2026
Learn how major industry trends are influencing the future of biopharma, including patent expiration challenges, evolving regulatory pathways, and emerging therapeutic targets that are attracting significant investment and attention. Source: PharmaVoice A wave of patent expirations is expected to put more than $500 billion in global prescription drug sales at
Industry Happenings -September 2026
FDA policy, shifting R&D priorities, and heightened oversight of overseas trials are shaping the future of drug development. Don’t miss the latest in BioPharma! Source: PharmaVoice The upcoming reauthorization of the Prescription Drug User Fee Act (PDUFA) could create an opening for Congress to streamline U.S. clinical trials as competition
132 Speakers. Three Leadership Changes. No Compromise on Speaker Readiness: A Case Study
Business throws a lot of curveballs. Deadlines tighten. Priorities shift. And sometimes, leadership changes overnight. When you’re navigating that kind of disruption, having a partner who already knows your business can make all the difference. There’s no time to start from scratch or get up to speed on what needs
Industry Insights – August 2026
Stay in tune with the growing changes in drug access and regulatory transparency, including rising insurance denials for brand-name medications and FDA updates around rejection letters and advisory committees. Read on for a closer look at developments shaping the biopharma industry. Source: PharmaVoice Insurance denials for brand-name prescription drugs have
Is Your Congress Strategy Driving Growth or Draining Your Budget?
Before your team commits another dollar to an association congress meeting, ask yourself: Will this meeting move your brand forward or simply add another expense?¹ The challenge is not whether you are showing up; it is whether you are showing up in the right events. How well do you know the
Will Your Launch Strategy Succeed or Fail?
The Challenge: A Faster, More Complex Launch Environment In today’s pharmaceutical market, strong science is the foundation, but it doesn’t always guarantee a successful launch. Many of us have experienced a disappointing launch when everything we anticipated pointed to success. Today, launches are more complex than they were a decade
Industry Insights – June 2026
From evolving China deal dynamics and prolonged job searches to the growing push for AI-driven drug repurposing, explore how shifts in BioPharma are redefining innovation, hiring, and strategy across the sector. Don’t miss the latest: Source: PharmaVoice The FDA is ramping up efforts to identify new uses for existing drugs,
Industry Insights – May 2026
Biosimilars are gaining U.S. momentum even as patent thickets keep triggering legal fights, small biotechs are feeling the pressure of the FDA’s faster-moving approval environment, and the agency is testing real-time clinical trial review with big-name drugmakers already on board. It’s a fast-changing drug-development landscape worth watching. Don’t miss the